stella
beta
Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System — Stella
Home
/
Focal Segmental Glomerulosclerosis
/
Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
View on ClinicalTrials.gov
Recruiting
Back to Focal Segmental Glomerulosclerosis trials
Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(10 sites)
United States
Loma Linda University Children's Hospital, Loma Linda, California
Loma Linda University Hospital, Loma Linda, California
Nemours/Alfred I DuPont Hospital for Children, Wilmington, Delaware
Helen DeVos Children's Hospital, Grand Rapids, Michigan
Weill Cornell Medicine / NewYork-Presbyterian, New York, New York
University of North Carolina, Chapel Hill, North Carolina
Akron Children's Hospital, Akron, Ohio
Medical University of South Carolina Children's Hospital, Charleston, South Carolina
Medical University of South Carolina, Charleston, South Carolina
Children's Hospital of Richmond at VCU, Richmond, Virginia